Clinical Trial Update: Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating immune responses to the IXIARO Japanese Encephalitis vaccine (batch JEV09L37) before and after revaccination has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• IXIARO (inactivated Japanese encephalitis vaccine)

Snippet

Sponsor: Valneva Austria GmbH | Conditions: Japanese Encephalitis | Phase 1 | Status: WITHDRAWN